EFFECT OF IPTACOPAN ON PROTEINURIA AND COMPLEMENT BIOMARKERS OVER TIME IN IGA NEPHROPATHY
Back
Abstract Number
WCN23-0412
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Other CKD
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
EFFECT OF IPTACOPAN ON PROTEINURIA AND COMPLEMENT BIOMARKERS OVER TIME IN IGA NEPHROPATHY
Co-authors
Barratt, J.(1,2)*;Rovin, B.H.(3);Zhang, H.(4);Rizk, D.V.(5);Kashihara, N.(6);Maes, B.D.(7);Trimarchi, H.(8);Sprangers, B.(9);Meier, M.(10);Kollins, D.(10);Junge, G.(11);Milojevic, J.(11);Papachristofi, O.(10);Perkovic, V.(12);
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)University Of Leicester, Department Of Cardiovascular Sciences, Leicester, United Kingdom;(2)University Hospitals Of Leicester, Nhs Trust, Leicester, United Kingdom;(3)The Ohio State University, Wexner Medical Centre, Columbus- Oh, United States;(4)Peking University First Hospital, Department Of Nephrology Renal Division, Beijing, China;(5)The University Of Alabama At Birmingham, School Of Medicine, Birmingham- Al, United States;(6)Kawasaki Ika Daigaku Jinzo, Koketsuatsu Naikagaku Kyoshitsu, Okayama, Japan;(7)Az Delta Vzw, Roeselare, West-Vlaanderen, Belgium;(8)Hospital Britanico De Buenos Aires, Buenos Aires, Federal District, Argentina;(9)Katholieke Universitet Leuven Universitaire Ziekenhuizen Leuven Campus Gasthuisberg, Leuven, Flanders, Belgium;(10)Novartis Pharma Ag, Global Drug Development, Basel, Switzerland;(11)Novartis Institutes For Biomedical Research, Basel Department Of Translational Medicine, Basel, Switzerland;(12)University Of New South Wales, Sydney, New South Wales, Australia;
E-Poster
https://storage.unitedwebnetwork.com/files/1041/b6b22bbbf6ce81d006600c33551e7611.pdf
Audio File
if any